Institutional investors purchased a net $36.2 thousand shares of CBLI during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 2.25% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MB FINANCIAL BANK, NA (TRUST DEP... Sold 16.00 shares of Cleveland Biolabs Inc